文献
J-GLOBAL ID:202202258732447062
整理番号:22A1051140
古典的または固有のカポジ肉腫におけるペンブロリズマブによるPD-1遮断: 多施設,単腕,第2相試験【JST・京大機械翻訳】
PD-1 blockade with pembrolizumab in classic or endemic Kaposi’s sarcoma: a multicentre, single-arm, phase 2 study
著者 (26件):
Delyon Julie
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Delyon Julie
(Department of Dermatology, DMU ICARE, AP-HP Saint-Louis Hospital, Paris, France)
,
Biard Lucie
(Universite Paris Cite, INSERM U1153, Team ECSTRRA, Paris, France)
,
Biard Lucie
(Department of Biostatistics and Medical Information, AP-HP Saint-Louis Hospital, Paris, France)
,
Renaud Marion
(Department of Dermatology, DMU ICARE, AP-HP Saint-Louis Hospital, Paris, France)
,
Resche-Rigon Matthieu
(Universite Paris Cite, INSERM U1153, Team ECSTRRA, Paris, France)
,
Resche-Rigon Matthieu
(Department of Biostatistics and Medical Information, AP-HP Saint-Louis Hospital, Paris, France)
,
Le Goff Jerome
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Le Goff Jerome
(Department of Virology, AP-HP Saint-Louis Hospital, Paris, France)
,
Dalle Stephane
(Department of Dermatology, Hopital Lyon-Sud, Immucare, Centre de Recherche en Cancerologie de Lyon, Universite Claude Bernard Lyon 1, Lyon, France)
,
Heidelberger Valentine
(Department of Dermatology, AP-HP Hopital Avicenne, Bobigny, France)
,
Da Meda Laetitia
(Department of Dermatology, DMU ICARE, AP-HP Saint-Louis Hospital, Paris, France)
,
Toullec Laurie
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Toullec Laurie
(Department of Immunology and Histocompatibility, DMU PRISME, AP-HP Saint-Louis Hospital, Paris, France)
,
Carcelain Guislaine
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Carcelain Guislaine
(Department of Immunology, AP-HP Robert Debre hospital, Paris France)
,
Mourah Samia
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Mourah Samia
(Department of Genomics of Solid Tumors and Pharmacology, AP-HP Saint-Louis Hospital, Paris, France)
,
Caillat-Zucman Sophie
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Caillat-Zucman Sophie
(Department of Immunology and Histocompatibility, DMU PRISME, AP-HP Saint-Louis Hospital, Paris, France)
,
Allain Vincent
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Allain Vincent
(Department of Immunology and Histocompatibility, DMU PRISME, AP-HP Saint-Louis Hospital, Paris, France)
,
Battistella Maxime
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Battistella Maxime
(Department of Pathology, AP-HP Saint-Louis Hospital, Paris, France)
,
Lebbe Celeste
(Universite Paris Cite, INSERM U976 HIPI, Paris, France)
,
Lebbe Celeste
(Department of Dermatology, DMU ICARE, AP-HP Saint-Louis Hospital, Paris, France)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
23
号:
4
ページ:
491-500
発行年:
2022年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)